| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.001 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.004 |